Insights into chimeric antigen receptor therapy for chronic lymphoblastic leukemia Journal Article

  


Authors: Hamieh, M.; Sadelain, M.
Article Title: Insights into chimeric antigen receptor therapy for chronic lymphoblastic leukemia
Abstract: In a recent study, Fraietta and colleagues identified chimeric antigen receptor (CAR) T cell biomarkers that may predict the success or failure of CAR therapy in patients with refractory chronic lymphoblastic leukemia (CLL). These findings open new prospects for improving T cell product manufacturing and the management of patients with CLL undergoing T cell-based therapies. © 2018 Elsevier Ltd
Journal Title: Trends in Molecular Medicine
Volume: 24
Issue: 9
ISSN: 1471-4914
Publisher: Elsevier Inc.  
Date Published: 2018-09-01
Start Page: 729
End Page: 731
Language: English
DOI: 10.1016/j.molmed.2018.06.007
PROVIDER: scopus
PUBMED: 30149852
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049313066&doi=10.1016%2fj.molmed.2018.06.007&partnerID=40&md5=3295c3f445026d246cfa94b9ca010c91
Notes: Short Survey -- Export Date: 4 September 2018 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michel W J Sadelain
    583 Sadelain
  2. Mohamad Hamieh
    27 Hamieh
Related MSK Work